Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3671 GEP-NET and early progression after RLT – Application of a modified TGR to increase the accuracy of prediction

Introduction: Tumor Growth Rate (TGR) allows for early SSA and RLT response assessment in NET.

Conference:

Presenting Author: Scalorbi F

Authors: Scalorbi F, Calareso G, Garanzini E, Prinzi N, Pusceddu S,

Keywords: TGR, RLT, NET,

#3531 Modified TGR: A new strong radiological marker to accurately predict early response to PRRT in GEP-NETs

Introduction: .

Conference:

Presenting Author:

Authors: Scalorbi F, Calareso G, Garanzini E, Argiroffi G, Fuoco V,

Keywords: gep-net, prrt, tgr, progression, predictive model,

#3511 Predictive factors of adverse events onset in GEP-NET patients treated with LRT

Introduction: Since metastatic GEP-NET are low-growing neoplasms, characterised by stability followed by progression, multiple lines of treatment have to be adopted to control distant localisations and symptoms. In this scenario, there are no precise models to assess the occurrence of adverse events during LRT (Ligand Radiotherapy).

Conference:

Presenting Author: Scalorbi F

Authors: Scalorbi F, Argiroffi G, Baccini M, Gherardini L, Fuoco V,

Keywords: lrt, toxicity, logistic regression, predictive model, gep-net,

#3230 Single-institution real-life experience of 177Lu-DOTATATE treatment in progressive, well-differentiated GEP-NETs

Introduction: -

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Federica S

Authors: Scalorbi F, Maccauro M, Lorenzoni A, Fuoco V, Argiroffi G,

Keywords: GEP-NET, G1, G2, PRRT, 117Lu-DOTA peptides, toxicity, interim evaluation,

#2863 Introduction of Dosimetry on PRRT Practice. A Useful Tool to Detect Responders and Evaluate Treatment Safety

Introduction: PRRT is a recognized salvage option for G1-G2 GEPNET. Currently, the Italian protocol (Lutathera AIFA Guidelines) consists in four fixed-dose of 177 Lu-DOTATATE. The dosimetry has recently been recognized as an important tool to guide PRRT but is not yet part of routine practice.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: SCALORBI F

Authors: Scalorbi F, Mazzaglia S, Maccauro M, Chiesa C, Prinzi N,

Keywords: prrt, healthy tissue and target lesion dosimetry, gastroenteropancreatic neuroendocrine tumor,